XP-23829, a Novel Fumaric Acid Ester, Is Efficacious in Reducing Psoriatic Lesions: Results from a Phase 2 Randomized Controlled Study. J of Skin 2017, 1 (3.1), s33. https://doi.org/10.25251/skin.1.supp.32.